<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01184014</url>
  </required_header>
  <id_info>
    <org_study_id>04000-10-C</org_study_id>
    <nct_id>NCT01184014</nct_id>
  </id_info>
  <brief_title>Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia</brief_title>
  <official_title>Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HealthPartners Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Diabetes Center at Park Nicollet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>HealthPartners Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the best insulin regimen for hospitalized
      patients who receive high doses of steroids who have high blood glucose.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall study objective of this research is to establish the efficacy and assure the
      safety of achieving glycemic control in hospitalized patients who receive greater than
      physiologic doses of steroids. This study will compare 2 methods of achieving glycemic
      control in hospitalized patients who develop steroid-induced hyperglycemia (blood glucose
      (BG) &gt;180 mg/dL): 1) a study-specific steroid NPH dosing algorithm plus standard recommended
      care (Experimental group) vs. 2) the standard recommended care (Methodist Hospital Complete
      Insulin Orders (Control group).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Blood Glucose of All Readings</measure>
    <time_frame>starting 3 hours after the initial index BG&gt;180 measure, across the entire hospital stay or up through 5 days if hospital LOS is &gt; 5 days</time_frame>
    <description>Starting 3 hours after the initial index blood glucose (BG) &gt;180 measure, across the entire hospital stay or up through 5 days if hospital length of stay (LOS) is &gt; 5 days</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Hyperglycemia</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a study-specific steroid (NPH) dosing algorithm plus standard recommended care. The intervention is Neutral Protamine Hagedorn (NPH) insulin plus complete insulin orders (CIO).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the standard recommended care (Methodist Hospital Complete Insulin Orders)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NPH insulin plus Complete Insulin Orders</intervention_name>
    <description>NPH dosed per study-specific algorithm which incorporates total daily dosage of steroid to determine NPH dose. Complete insulin orders include background, meal-time and correction factor.</description>
    <arm_group_label>Experimental group</arm_group_label>
    <other_name>lantus</other_name>
    <other_name>glargine</other_name>
    <other_name>humalog</other_name>
    <other_name>lispro</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Complete Insulin Orders</intervention_name>
    <description>3-part insulin which includes background, meal-time and correction factor</description>
    <arm_group_label>Control group</arm_group_label>
    <other_name>lantus</other_name>
    <other_name>glargine</other_name>
    <other_name>humalog</other_name>
    <other_name>lispro</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men or women aged ≥18 years who receive steroids in doses greater than physiologic
             replacement levels of ≥ 10 mg Prednisone or its equivalent of dexamethasone or
             methylprednisolone.

          -  Have signed the consent form for the study

          -  Have a BG &gt; 180 mg/dL any time during the first 24 hour of steroid administration that
             is above physiological replacement ( ≥ 10 mg Prednisone or equivalent)

          -  Are scheduled to be in hospital ≥ 2 days.

        Exclusion Criteria:

          -  Unable to read or understand English

          -  History of psychiatric disability affecting informed consent or compliance with drug
             intake

          -  Type 1 diabetes

          -  Acute or chronic renal failure (creatinine clearance &lt; 30 mL/min estimated by method
             of Cockcroft and Gault)

          -  Patients in Hospice Care

          -  Age &lt;18 years

          -  Previously enrolled in this study.

          -  Not appropriate for the steroid protocol in judgment of the principal investigator
             and/or attending physician.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard M Bergenstal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Diabetes Center at Park Nicollet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Park Nicollet Health Services Methodist Hospital</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009 Jul-Aug;15(5):469-74. doi: 10.4158/EP08331.RAR. Review.</citation>
    <PMID>19454391</PMID>
  </reference>
  <reference>
    <citation>Derendorf H, Hochhaus G, Möllmann H, Barth J, Krieg M, Tunn S, Möllmann C. Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids. J Clin Pharmacol. 1993 Feb;33(2):115-23.</citation>
    <PMID>8440759</PMID>
  </reference>
  <reference>
    <citation>Donihi AC, Raval D, Saul M, Korytkowski MT, DeVita MA. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006 Jul-Aug;12(4):358-62.</citation>
    <PMID>16901792</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2010</study_first_submitted>
  <study_first_submitted_qc>August 17, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2010</study_first_posted>
  <results_first_submitted>September 13, 2013</results_first_submitted>
  <results_first_submitted_qc>September 13, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 18, 2013</results_first_posted>
  <last_update_submitted>April 11, 2018</last_update_submitted>
  <last_update_submitted_qc>April 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>corticosteroid</keyword>
  <keyword>hyperglycemia</keyword>
  <keyword>hospital</keyword>
  <keyword>corticosteroid induced hyperglycemia in the hospital</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Isophane insulin, beef</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin Glargine</mesh_term>
    <mesh_term>Insulin Lispro</mesh_term>
    <mesh_term>Insulin, Isophane</mesh_term>
    <mesh_term>Isophane Insulin, Human</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment from May 2011 to August 2012. Location: Hospital.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Experimental Group</title>
          <description>a study-specific steroid NPH dosing algorithm plus standard recommended care</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>the standard recommended care (Methodist Hospital Complete Insulin Orders)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Experimental Group</title>
          <description>a study-specific steroid NPH dosing algorithm plus standard recommended care</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>the standard recommended care (Methodist Hospital Complete Insulin Orders)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="35"/>
            <count group_id="B2" value="37"/>
            <count group_id="B3" value="72"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.1" spread="14.2"/>
                    <measurement group_id="B2" value="71.6" spread="44.6"/>
                    <measurement group_id="B3" value="69.4" spread="33.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Blood Glucose of All Readings</title>
        <description>Starting 3 hours after the initial index blood glucose (BG) &gt;180 measure, across the entire hospital stay or up through 5 days if hospital length of stay (LOS) is &gt; 5 days</description>
        <time_frame>starting 3 hours after the initial index BG&gt;180 measure, across the entire hospital stay or up through 5 days if hospital LOS is &gt; 5 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>a study-specific steroid (NPH) dosing algorithm plus standard recommended care. The intervention is Neutral Protamine Hagedorn (NPH) insulin plus complete insulin orders (CIO).
NPH insulin plus Complete Insulin Orders: NPH dosed per study-specific algorithm which incorporates total daily dosage of steroid to determine NPH dose. Complete insulin orders include background, meal-time and correction factor.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>the standard recommended care (Methodist Hospital Complete Insulin Orders)
Complete Insulin Orders: 3-part insulin which includes background, meal-time and correction factor</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Blood Glucose of All Readings</title>
          <description>Starting 3 hours after the initial index blood glucose (BG) &gt;180 measure, across the entire hospital stay or up through 5 days if hospital length of stay (LOS) is &gt; 5 days</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="157.2" spread="6.1"/>
                    <measurement group_id="O2" value="181.8" spread="32.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data collected over complete length of inpatient stay.</time_frame>
      <desc>All subjects glucose level tests were reviewed looking for incidence of severe hypoglycemia (&lt; 50 mg/dL)</desc>
      <group_list>
        <group group_id="E1">
          <title>Experimental Group</title>
          <description>a study-specific steroid NPH dosing algorithm plus standard recommended care</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>the standard recommended care (Methodist Hospital Complete Insulin Orders)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Richard Bergenstal</name_or_title>
      <organization>International Diabetes Center</organization>
      <phone>952-993-3796</phone>
      <email>richard.bergenstal@parknicollet.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

